Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Antiviral Activity of Clevudine in Hepatitis B
NCT00305019Phase 2Terminated
- Sponsor
- Bukwang Pharmaceutical
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clevudine in hepatitis B (HBV), sponsored by Bukwang Pharmaceutical. Started Jul 2002; status: terminated.
02
Drugs
clevudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00305019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305019.